Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
ESHO 2024
Programm
Personen
Suche
DE
Zurück
Scientific session
Session 8
HIPEC-HIFU
Termin
Datum:
08.11.2024
Zeit:
09:00
–
10:30
Ort / Stream:
Aula 5
Chair
Dr. Cesar Ramirez
Málaga / ES
Dr. Johannes Crezee
Amsterdam / NL
Programm
09:00
–
09:20
15 Min.
5 Min.
Invited Talk
IT-08
State-of-the-Art in Intraperitoneal Hyperthermia: Current Indications and Evolving Controversies
Dr. Juan José Segura-Sampedro (Madrid / ES)
09:20
–
09:32
9 Min.
3 Min.
Oral Presentation
OP-33
Feasibility and safety of MR guided high intensity focused ultrasound-induced hyperthermia in large volume near bone structure
Mona Ayary (köln / DE)
Technology developments
09:32
–
09:44
9 Min.
3 Min.
Oral Presentation
OP-35
Temperature optimization for locoregional hyperthermia accounting for tissue-property uncertainties using polynomial chaos expansion
Timoteo Daniel Herrera (Amsterdam / NL)
Q&A: thermometry, treatment planning, image guide
09:44
–
09:46
2 Min.
0 Min.
Flash Presentation
FP-31
In silico
analysis of step-up heating protocols to improve the effectiveness of oxaliplatin-based HIPEC
Pouya Namakshenas (Amsterdam / NL)
HIPEC
09:46
–
09:48
2 Min.
0 Min.
Flash Presentation
FP-32
Advancement in the development of a modular, human body-mimicking phantom with active thermoregulation capabilities
Laurent Van den Bossche (Leuven / BE)
Technology developments
09:48
–
09:50
2 Min.
0 Min.
Flash Presentation
FP-33
Increasing the quality of life in bladder cancer patients by Heckel-HT3000
Dr. Sopio Badzgaradze (Kutaisi / GE)
Hyperthermia clinical applications: radio-chemo-immunotherapy
09:50
–
09:52
2 Min.
0 Min.
Flash Presentation
FP-34
The pleiotropic effects of whole-body hyperthermia in synergizing chemotherapy and enhancing immune response in pancreatic ductal adenocarcinoma
Tine Logghe (Mechelen / BE)
Basic research in Hyperthermia: biological-immune response
09:52
–
09:54
2 Min.
0 Min.
Flash Presentation
FP-35
Development of an anticancer tissue adhesive for intraperitoneal chemotherapy as an adjuvant to HIPEC
Dr. Juan José Segura-Sampedro (Madrid / ES)
HIPEC
09:54
–
09:56
2 Min.
0 Min.
Flash Presentation
FP-36
Establishment of a murine model of localised advanced ovarian cancer to test this novel intraperitoneal drug delivery system
Dr. Juan José Segura-Sampedro (Madrid / ES)
Emerging topics
09:56
–
09:58
2 Min.
0 Min.
Flash Presentation
FP-37
Does repeated fever-range whole body hyperthermia treatments reduce patient's capacity to rise body temperature?
Dr João Moreira Pinto (Lisboa / PT)
Hyperthermia clinical applications: radio-chemo-immunotherapy
09:58
–
10:10
9 Min.
3 Min.
Oral Presentation
OP-34
The role of regional deep hyperthermia (RHT) and hyperthermic intraperitoneal chemotherapy (HIPEC) in children and adolescents with disseminated abdominal desmoplastic small round cell tumors (DSRCT)
Rüdiger Wessalowski (Duesseldorf / DE)
Hyperthermia clinical applications: radio-chemo-immunotherapy
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz